DAVIS C GEOFFREY 4
4 · ABGENIX INC · Filed Apr 16, 2004
Insider Transaction Report
Form 4
ABGENIX INCABGX
DAVIS C GEOFFREY
Chief Scientific Officer
Transactions
- Sale
Common Stock
2004-04-14$13.33/sh−31,760$423,297→ 14,198 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2004-04-14−13,748→ 19,645 totalExercise: $8.87Exp: 2010-04-02→ Common Stock (13,748 underlying) - Exercise/Conversion
Common Stock
2004-04-14$8.87/sh+13,748$121,945→ 27,946 total - Exercise/Conversion
Common Stock
2004-04-14$3.75/sh+31,760$119,100→ 45,958 total - Sale
Common Stock
2004-04-14$13.33/sh−13,748$183,233→ 14,198 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2004-04-14−31,760→ 0 totalExercise: $3.75Exp: 2009-01-12→ Common Stock (31,760 underlying)
Footnotes (2)
- [F1]1/48 of the total shares subject to the option became exercisable on February 12, 1999 and an additional 1/48 of the total shares subject to the option became exercisable each full month thereafter.
- [F2]3/48 of the total shares subject to the option became exercisable on April 2, 2003 and an additional 1/48 of the total shares subject to the option become exercisable each full month thereafter.